Richard A. Gonzalez
2017 - AbbVie
In 2017, Richard A. Gonzalez earned a total compensation of $22.6M as Chairman of the Board and Chief Executive Officer at AbbVie, a 8% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,496,704 |
|---|---|
| Non-Equity Incentive Plan | $4,331,250 |
| Option Awards | $2,559,270 |
| Salary | $1,638,462 |
| Stock Awards | $9,606,360 |
| Other | $993,197 |
| Total | $22,625,243 |
Gonzalez received $9.6M in stock awards, accounting for 42% of the total pay in 2017.
Gonzalez also received $3.5M of change in pension value and nonqualified deferred compensation earnings, $4.3M in non-equity incentive plan, $2.6M in option awards, $1.6M in salary and $993.2K in other compensation.
Rankings
In 2017, Richard A. Gonzalez's compensation ranked 110th out of 14,666 executives tracked by ExecPay. In other words, Gonzalez earned more than 99.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 110 out of 14,666 | 99th |
Division Manufacturing | 31 out of 5,770 | 100th |
Major group Chemicals And Allied Products | 8 out of 2,074 | 100th |
Industry group Drugs | 7 out of 1,730 | 100th |
Industry Pharmaceutical Preparations | 6 out of 1,329 | 100th |
Source: SEC filing on March 19, 2018.
Gonzalez's colleagues
We found four more compensation records of executives who worked with Richard A. Gonzalez at AbbVie in 2017.